Propulsion of Small Lymphocytic Lymphoma Clinical Trial
The global Small Lymphocytic Lymphoma Treatment market has significantly grown over the past few years and is expected to register rapid growth. Revenue...
Stay updated with breaking news from Evive Biotech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The global Small Lymphocytic Lymphoma Treatment market has significantly grown over the past few years and is expected to register rapid growth. Revenue...
/PRNewswire/ -- Nona Biosciences, a global pioneer of technology innovation and antibody discovery and development solutions, and Evive Biotech, a global...
Following the approval of Toripalimab by the Food and Drug Administration, two more Chinese-made cancer drugs have received approval for distribution in the US.
The new colony-stimulating factor from China proved comparable to pegfilgrastim (Neulasta) in clinical testing.
Hyderabad: Pharma major Aurobindo Pharma on Wednesday said the US Food & Drug Administration (USFDA) has approved Ryzneuta (Efbemalenograstim alfa inj.